Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Cash (2018 - 2025)

TransMedics has reported Change in Cash over the past 8 years, most recently at $22.2 million for Q4 2025.

  • Quarterly results put Change in Cash at $22.2 million for Q4 2025, up 238.5% from a year ago — trailing twelve months through Dec 2025 was $151.7 million (up 360.85% YoY), and the annual figure for FY2025 was $151.7 million, up 360.85%.
  • Change in Cash for Q4 2025 was $22.2 million at TransMedics, down from $65.6 million in the prior quarter.
  • Over the last five years, Change in Cash for TMDX hit a ceiling of $386.8 million in Q2 2023 and a floor of -$155.4 million in Q3 2023.
  • Median Change in Cash over the past 5 years was $366500.0 (2021), compared with a mean of $23.2 million.
  • Biggest five-year swings in Change in Cash: surged 6275.1% in 2022 and later crashed 884.7% in 2023.
  • TransMedics' Change in Cash stood at $3.1 million in 2021, then tumbled by 206.32% to -$3.3 million in 2022, then crashed by 884.7% to -$32.3 million in 2023, then soared by 120.3% to $6.6 million in 2024, then soared by 238.5% to $22.2 million in 2025.
  • The last three reported values for Change in Cash were $22.2 million (Q4 2025), $65.6 million (Q3 2025), and $90.4 million (Q2 2025) per Business Quant data.